Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Reviewer Acknowledgements for International Business Research, Vol. 16, No. 6
View through CrossRef
Reviewer Acknowledgements for International Business Research, Vol. 16, No. 6, 2023
Title: Reviewer Acknowledgements for International Business Research, Vol. 16, No. 6
Description:
Reviewer Acknowledgements for International Business Research, Vol.
16, No.
6, 2023.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
The Motley Editorial Team
The Motley Editorial Team
Meet Dr. Maria Bakardjieva, Managing Editor, Melissa Morris, and the team of undergraduate and graduate students that have worked to build The Motley's first issue this year!
Maria...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
How reviewer level affects review helpfulness and reviewing behavior across hotel classifications: the case of Seoul in Korea
How reviewer level affects review helpfulness and reviewing behavior across hotel classifications: the case of Seoul in Korea
PurposeThe purpose of this study is to explore the effect of reviewer qualification and credibility (RQC) and hotel classification involving online hotel reviews (OHRs). The study ...
Improving Code Reviewer Recommendation: Accuracy, Latency, Workload, and Bystanders
Improving Code Reviewer Recommendation: Accuracy, Latency, Workload, and Bystanders
Aim
. The code review team at Meta is continuously improving the code review process. In this work, we report on three randomized controlled experimental trials...
Who is a reviewer? The Good, the Bad, and the Ugly phenotypes
Who is a reviewer? The Good, the Bad, and the Ugly phenotypes
By offering their expertise, reviewers help authors improve their work and also support editors in selecting high-quality studies, thereby reinforcing the integrity of scientific l...